Human APOC1 ELISA Kit (V2LY-0626-LY3514)

Name: Human APOC1 ELISA Kit
SKU: V2LY-0626-LY3514
Rating: 5 (1 reviews)

See all APOC1 antibodies

Compare Online Inquiry

Tested Data

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Sensitivity

0.054 μg/mL

Detection Range

0.1-40 μg/mL

Sample Type

Serum, Plasma, cell culture supernates

Specificity

Human

Assay Type

Sandwich

Reactivity

Human

Assay Time

1.5 h

Molecule Mass

9.3 kDa

Components

Pre-coated ELISA Plate: 12 wells * 8 detachable strips
Standard solution: 0.5ml x1
Standard diluent: 3ml x1
Streptavidin-HRP: 6ml x1
Stop solution: 6ml x1
Substrate solution A: 6ml x1
Substrate solution B: 6ml x1
Wash buffer concentrate (25x): 20ml x1
Biotinylated antibody: 1ml x1

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage

Store at 2-8°C

More Infomation

Target

Full Name

apolipoprotein C-I

Function

Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10% of the protein of the VLDL and 2% of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.

Biological Process

Cholesterol efflux Source: BHF-UCL
Chylomicron remnant clearance Source: BHF-UCL
High-density lipoprotein particle remodeling Source: BHF-UCL
Intracellular receptor signaling pathway Source: Reactome
Lipid metabolic process Source: ProtInc
Lipoprotein metabolic process Source: InterPro
Negative regulation of cholesterol transport Source: BHF-UCL
Negative regulation of fatty acid biosynthetic process Source: BHF-UCL
Negative regulation of lipid catabolic process Source: BHF-UCL
Negative regulation of lipid metabolic process Source: BHF-UCL
Negative regulation of lipoprotein lipase activity Source: BHF-UCL
Negative regulation of phosphatidylcholine catabolic process Source: BHF-UCL
Negative regulation of receptor-mediated endocytosis Source: BHF-UCL
Negative regulation of very-low-density lipoprotein particle clearance Source: BHF-UCL
Phospholipid efflux Source: BHF-UCL
Plasma lipoprotein particle remodeling Source: BHF-UCL
Positive regulation of cholesterol esterification Source: BHF-UCL
Regulation of cholesterol transport Source: BHF-UCL
Triglyceride metabolic process Source: GO_Central
Very-low-density lipoprotein particle assembly Source: BHF-UCL
Very-low-density lipoprotein particle clearance Source: BHF-UCL

Cellular Location

Secreted

Xiao, H., & Xu, Y. (2021). Overexpression of Apolipoprotein C1 (APOC1) in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 27, e929347-1.

Jiang, H., Tang, J. Y., Xue, D., Chen, Y. M., Wu, T. C., Zhuang, Q. F., & He, X. Z. (2021). Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling. Cancer cell international, 21(1), 1-12.

Wang, H. J., Ma, Y. X., Wang, A. H., Jiang, Y. S., & Jiang, X. Z. (2021). Expression of apolipoprotein C1 in clear cell renal cell carcinoma: An oncogenic gene and a prognostic marker. The Kaohsiung Journal of Medical Sciences, 37(5), 419-426.

Cui, Y., Miao, C., Liu, B., Wang, Z., & Hou, C. (2020). Apolipoprotein C1 (APOC1): a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma. Frontiers in Oncology, 10, 1436.

Shi, X., Wang, J., Dai, S., Qin, L., Zhou, J., & Chen, Y. (2020). Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer. OncoTargets and therapy, 13, 12881.

Ren, H., Chen, Z., Yang, L., Xiong, W., Yang, H., Xu, K., ... & Song, X. (2019). Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer. Cancer management and research, 11, 4917.

Yi, J., Ren, L., Wu, J., Li, W., Zheng, X., Du, G., & Wang, J. (2019). Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer. Annals of translational medicine, 7(16).

Fuior, E. V., & Gafencu, A. V. (2019). Apolipoprotein C1: its pleiotropic effects in lipid metabolism and beyond. International journal of molecular sciences, 20(23), 5939.

Su, W. P., Sun, L. N., Yang, S. L., Zhao, H., Zeng, T. Y., Wu, W. Z., & Wang, D. (2018). Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro. Journal of biochemical and molecular toxicology, 32(7), e22158.

Zhang, H., Qiao, L., & Luo, G. (2018). Characterization of apolipoprotein C1 in hepatitis C virus infection and morphogenesis. Virology, 524, 1-9.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Human APOC1 ELISA Kit?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-APOC1 Recombinant Antibody (CBYC-A689) (CAT#: CBMAB-A3193-YC)

Mouse Anti-APOC1 Recombinant Antibody (2E2-1A3) (CAT#: CBMAB-A3192-YC)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry